If ACE-I or ARB is not tolerated, then diuretics, CCBs, and beta- blockers should be considered ACE-I, angiotensin-converting enzyme inhibitor; ACR, albumin/creatinine ratio; ARB, angiotensin-receptor blocker; BP, blood pressure; CCB, calcium-channel blocker; CKD, chronic kidney disease; DKD, diabetic kidney disease; DM, diabetes mellitus; GFR, glomerular filtration rate. methods for guideline development Table 17 | The Conference on Guideline Standardization (COGS) checklist for reporting clinical practice guidelines Topic Description Discussed in KDIGO Management of Blood Pressure in Chronic Kidney Disease Guideline 1. Overview material Provide a structured abstract that includes the guideline s release date, status (original, revised, updated), and print and electronic sources. Abstract and Methods for Guideline Development. 2. Focus Describe the primary disease/condition and intervention/ service/technology that the guideline addresses. Indicate any alternative preventative, diagnostic or therapeutic interventions that were considered during development. Management of blood pressure and the use of anti-hypertensive agents in adults and children with CKD ND, including those with kidney transplants. 3. Goal Describe the goal that following the guideline is expected to achieve, including the rationale for development of a guideline on this topic. This clinical practice guideline is intended to assist the practitioner caring for patients with non-dialysis CKD and hypertension and to prevent deaths, CVD events, and progression to kidney failure while optimizing patients quality of life. 4. User/setting Describe the intended users of the guideline (e.g., provider types, patients) and the settings in which the guideline is intended to be used. Providers: Nephrologists (adult and pediatric), Internists, and Pediatricians. Patients: Adults and children with CKD at risk for hypertension. Policy Makers: Those in related health fields. 5. Target population Describe the patient population eligible for guideline recommendations and list any exclusion criteria. Adults and children with CKD, not on dialysis; kidney transplant recipients. 6. 